Acquiring Company
Alkem Laboratories
Acquired Company
Occlutech Holding AG
Mumbai
SwitzerlandManufacturingBiotechnologyPharmaceuticalManufacturingBiotechnologyHealth CareMedical DeviceDescription
Alkem Laboratories has acquired a 55% majority stake in Swiss firm Occlutech for approximately ₹1,074 crore. This strategic move marks Alkem's entry into the MedTech sector, with plans to leverage Occlutech's capabilities in the growing medical device market. The acquisition is projected to generate significant revenue in the coming years as the MedTech market expands.
Quick answer
Alkem Laboratories is acquiring Occlutech Holding AG, announced February 16, 2026. Alkem Laboratories is based in Mumbai, Maharashtra, India.
- How much did Alkem Laboratories pay for Occlutech Holding AG?
- The deal value was not disclosed.
- What does Alkem Laboratories do?
- Alkem Laboratories Ltd. is an Indian multinational pharmaceutical company based in Mumbai.
- Where are Alkem Laboratories and Occlutech Holding AG based?
- Alkem Laboratories is based in Mumbai, Maharashtra, India. Occlutech Holding AG is based in Switzerland.
- Who are the decision-makers at Alkem Laboratories?
- Fundz holds 1 contact at Alkem Laboratories. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Pharmaceutical and Medical Device
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- CORONA Remedies acquires Wokadine® brand from Dr. Reddy's (March 31, 2026)
- Embecta to acquire Owen Mumford Holdings Limited (March 19, 2026)
- Kopran Limited to merge with Kopran Laboratories Limited (February 27, 2026)
- Merck acquires JSR Life Sciences' chromatography business (April 2, 2026)
- Eli Lilly to acquire Centessa Pharmaceuticals (March 31, 2026)
- Jubilant Ingrevia acquires Remidex Pharma completely (March 30, 2026)
Who to call at Alkem Laboratories, and when
When Alkem Laboratories changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Alkem Laboratories raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Alkem Laboratories, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Alkem Laboratories. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Alkem Laboratories makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Occlutech Holding AG?
Occlutech Holding AG was acquired by Alkem Laboratories, based in Mumbai. The deal was reported on February 16, 2026. Alkem Laboratories Ltd. is an Indian multinational pharmaceutical company based in Mumbai. Founded in 1973, it has become a significant player in both the Indian and global pharmaceutical markets. Alkem Laboratories is privately held and operates in Manufacturing.
When did Alkem Laboratories acquire Occlutech Holding AG?
Alkem Laboratories's acquisition of Occlutech Holding AG was reported on February 16, 2026. Alkem Laboratories has acquired a 55% majority stake in Swiss firm Occlutech for approximately ₹1,074 crore. This strategic move marks Alkem's entry into the MedTech sector, with plans to leverage Occlutech's capabilities in the growing medical device market. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Occlutech Holding AG do?
Occlutech specializes in minimally invasive cardiac implants. Founded in 2003, it develops devices for treating congenital heart disease and other cardiovascular conditions. It is a major player in the European market for these devices. It is privately held, operating in Manufacturing, and is based in Switzerland.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.